Clinical Trial Update: Multi-omics Analysis of Renal Cell Carcinoma Mechanisms; Drug Sensitivity Testing in Patient-Derived Cell-based Microtumors

View source ↗

Summary

This clinical trial update describes a study on multi-omics analysis of Renal cell carcinoma mechanisms and drug sensitivity testing in patient-derived microtum…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Renal Cell Carcinoma (Kidney Cancer) | Status: NOT_YET_RECRUITING